Cargando…
Immunomodulatory Nanosystems
Immunotherapy has emerged as an effective strategy for the prevention and treatment of a variety of diseases, including cancer, infectious diseases, inflammatory diseases, and autoimmune diseases. Immunomodulatory nanosystems can readily improve the therapeutic effects and simultaneously overcome ma...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724480/ https://www.ncbi.nlm.nih.gov/pubmed/31508270 http://dx.doi.org/10.1002/advs.201900101 |
_version_ | 1783449003207163904 |
---|---|
author | Feng, Xiangru Xu, Weiguo Li, Zhongmin Song, Wantong Ding, Jianxun Chen, Xuesi |
author_facet | Feng, Xiangru Xu, Weiguo Li, Zhongmin Song, Wantong Ding, Jianxun Chen, Xuesi |
author_sort | Feng, Xiangru |
collection | PubMed |
description | Immunotherapy has emerged as an effective strategy for the prevention and treatment of a variety of diseases, including cancer, infectious diseases, inflammatory diseases, and autoimmune diseases. Immunomodulatory nanosystems can readily improve the therapeutic effects and simultaneously overcome many obstacles facing the treatment method, such as inadequate immune stimulation, off‐target side effects, and bioactivity loss of immune agents during circulation. In recent years, researchers have continuously developed nanomaterials with new structures, properties, and functions. This Review provides the most recent advances of nanotechnology for immunostimulation and immunosuppression. In cancer immunotherapy, nanosystems play an essential role in immune cell activation and tumor microenvironment modulation, as well as combination with other antitumor approaches. In infectious diseases, many encouraging outcomes from using nanomaterial vaccines against viral and bacterial infections have been reported. In addition, nanoparticles also potentiate the effects of immunosuppressive immune cells for the treatment of inflammatory and autoimmune diseases. Finally, the challenges and prospects of applying nanotechnology to modulate immunotherapy are discussed. |
format | Online Article Text |
id | pubmed-6724480 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-67244802019-09-10 Immunomodulatory Nanosystems Feng, Xiangru Xu, Weiguo Li, Zhongmin Song, Wantong Ding, Jianxun Chen, Xuesi Adv Sci (Weinh) Reviews Immunotherapy has emerged as an effective strategy for the prevention and treatment of a variety of diseases, including cancer, infectious diseases, inflammatory diseases, and autoimmune diseases. Immunomodulatory nanosystems can readily improve the therapeutic effects and simultaneously overcome many obstacles facing the treatment method, such as inadequate immune stimulation, off‐target side effects, and bioactivity loss of immune agents during circulation. In recent years, researchers have continuously developed nanomaterials with new structures, properties, and functions. This Review provides the most recent advances of nanotechnology for immunostimulation and immunosuppression. In cancer immunotherapy, nanosystems play an essential role in immune cell activation and tumor microenvironment modulation, as well as combination with other antitumor approaches. In infectious diseases, many encouraging outcomes from using nanomaterial vaccines against viral and bacterial infections have been reported. In addition, nanoparticles also potentiate the effects of immunosuppressive immune cells for the treatment of inflammatory and autoimmune diseases. Finally, the challenges and prospects of applying nanotechnology to modulate immunotherapy are discussed. John Wiley and Sons Inc. 2019-06-21 /pmc/articles/PMC6724480/ /pubmed/31508270 http://dx.doi.org/10.1002/advs.201900101 Text en © 2019 The Authors. Published by WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Reviews Feng, Xiangru Xu, Weiguo Li, Zhongmin Song, Wantong Ding, Jianxun Chen, Xuesi Immunomodulatory Nanosystems |
title | Immunomodulatory Nanosystems |
title_full | Immunomodulatory Nanosystems |
title_fullStr | Immunomodulatory Nanosystems |
title_full_unstemmed | Immunomodulatory Nanosystems |
title_short | Immunomodulatory Nanosystems |
title_sort | immunomodulatory nanosystems |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724480/ https://www.ncbi.nlm.nih.gov/pubmed/31508270 http://dx.doi.org/10.1002/advs.201900101 |
work_keys_str_mv | AT fengxiangru immunomodulatorynanosystems AT xuweiguo immunomodulatorynanosystems AT lizhongmin immunomodulatorynanosystems AT songwantong immunomodulatorynanosystems AT dingjianxun immunomodulatorynanosystems AT chenxuesi immunomodulatorynanosystems |